[Nle4,D-Phe7]-α-MSH (acetate) 5 mg | ≥98% Cayman Chemical A peptide agonist of MC1R More Information Supplier Page × [Nle4,D-Phe7]-α-MSH (acetate)
[Nle4,D-Phe7]-α-MSH (acetate) 25 mg | ≥98% Cayman Chemical A peptide agonist of MC1R More Information Supplier Page × [Nle4,D-Phe7]-α-MSH (acetate)
[Nle4,D-Phe7]-α-MSH (acetate) 10 mg | ≥98% Cayman Chemical A peptide agonist of MC1R More Information Supplier Page × [Nle4,D-Phe7]-α-MSH (acetate)
[Nle4,D-Phe7]-α-MSH (acetate) 1 mg | ≥98% Cayman Chemical A peptide agonist of MC1R More Information Supplier Page × [Nle4,D-Phe7]-α-MSH (acetate)
ACTH (7-38) (human) (trifluoroacetate salt) 500 µg | ≥95% Cayman Chemical A peptide fragment of ACTH and an antagonist of MC2R More Information Supplier Page × ACTH (7-38) (human) (trifluoroacetate salt)
ACTH (7-38) (human) (trifluoroacetate salt) 5 mg | ≥95% Cayman Chemical A peptide fragment of ACTH and an antagonist of MC2R More Information Supplier Page × ACTH (7-38) (human) (trifluoroacetate salt)
ACTH (7-38) (human) (trifluoroacetate salt) 10 mg | ≥95% Cayman Chemical A peptide fragment of ACTH and an antagonist of MC2R More Information Supplier Page × ACTH (7-38) (human) (trifluoroacetate salt)
ACTH (7-38) (human) (trifluoroacetate salt) 1 mg | ≥95% Cayman Chemical A peptide fragment of ACTH and an antagonist of MC2R More Information Supplier Page × ACTH (7-38) (human) (trifluoroacetate salt)
